126 results
-
List item
Veterinary medicine European public assessment report (EPAR): Circovac
inactivated porcine circovirus type 2 (PCV2), Pigs (gilts and sows)
Date of authorisation: 21/06/2007, Revision: 12, Authorised, Last updated: 08/12/2021the virus particles with an emulsion. The resulting emulsion is … virus particles with an emulsion. The resulting emulsion is … -
List item
Suitability of the graduation of delivery devices for liquid dosage forms - Scientific guideline
Last updated: 01/02/2005solutions, suspensions and emulsions. … solutions, suspensions and emulsions. Liquid dosage forms for …
-
List item
National expert: Antonio Clavenna, European Medicines Agency (updated)
- Declaration of interests - 40.85 KB | PDF
- Curriculum Vitae - 40.6 KB | PDF
“Ospedale Maggiore” of Crema, Italy. 1.11 Committee for … -
List item
National expert: Emilio Perucca, Italian Medicines Agency (updated)
- Declaration of interests - 48.61 KB | PDF
- Curriculum Vitae - 131.22 KB | PDF
CRISTALLO, L., DE PASCALE, V., CREMA, A., CRAVERI, F., PERUCCA … BAMONTE, F., CRAVERI, F., CREMA, A., PERUCCA, E. and TEGGIA … POLONI, M., FRIGO, G.M. and CREMA, A. Pharmacokinetics of phenytoin … -
List item
National expert: Mickaelle Sachet, National Veterinary Medicines Agency (updated)
- Declaration of interests - 39.34 KB | PDF
- Curriculum Vitae - 38.98 KB | PDF
biotransformations, formulation, emulsions, microencapsulation, environment… 1994-1999 Engineering … -
List item
National expert: Victor Mangas Sanjuan, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.49 KB | PDF
- Curriculum Vitae - 54.38 KB | PDF
Bellés_Medall MD, García_Cremades M, Ferrando_Piqueres R … -
List item
National expert: Marta Morado, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.87 KB | PDF
- Curriculum Vitae - 34.29 KB | PDF
Rosado S, Morado M, Vallejo_Cremades MT, Martinez A, Vargas_Nuñez … -
List item
Human medicine European public assessment report (EPAR): Verkazia
ciclosporin, Conjunctivitis; Keratitis
Date of authorisation: 06/07/2018,
, 
, Revision: 7, Authorised, Last updated: 25/04/2023
-
List item
Human medicine European public assessment report (EPAR): Ikervis
ciclosporin, Corneal Diseases
Date of authorisation: 19/03/2015, Revision: 10, Authorised, Last updated: 27/02/2023 -
List item
Human medicine European public assessment report (EPAR): Lutetium (177Lu) chloride Billev (previously Illuzyce)
lutetium (177Lu) chloride, Radionuclide Imaging
Date of authorisation: 15/09/2022, Revision: 1, Authorised, Last updated: 08/12/2022 -
List item
Human medicine European public assessment report (EPAR): Bimervax
SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer – B.1.351-B.1.1.7 strains, COVID-19 virus infection
Date of authorisation: 30/03/2023,
, Authorised, Last updated: 05/04/2023
-
List item
National expert: Birgitte Giersing, European Medicines Agency (updated)
- Declaration of interests - 39.19 KB | PDF
- Curriculum Vitae - 36.02 KB | PDF
-
List item
National expert: Antonio Jose Almeida, National Authority Of Medicines And Health Products (updated)
- Declaration of interests - 39.98 KB | PDF
- Curriculum Vitae - 53.67 KB | PDF
-
List item
National expert: Ana Catarina Reis, National Authority Of Medicines And Health Products (updated)
- Declaration of interests - 39.71 KB | PDF
- Curriculum Vitae - 53.15 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Elebrato Ellipta
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 15/11/2017, Revision: 11, Authorised, Last updated: 22/03/2023 -
List item
Human medicine European public assessment report (EPAR): Trelegy Ellipta
fluticasone furoate, umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 15/11/2017, Revision: 10, Authorised, Last updated: 22/03/2023 -
List item
Human medicine European public assessment report (EPAR): Neofordex (updated)
dexamethasone, Multiple Myeloma
Date of authorisation: 16/03/2016, Revision: 11, Authorised, Last updated: 17/05/2023 -
List item
Human medicine European public assessment report (EPAR): VidPrevtyn Beta
SARS-CoV-2 prefusion Spike delta TM protein, recombinant (B.1.351 strain), COVID-19 virus infection
Date of authorisation: 10/11/2022,, Authorised, Last updated: 30/11/2022
-
List item
Veterinary medicine European public assessment report (EPAR): Nobilis OR Inac
inactivated whole cell suspension of Ornithobacterium rhinotracheale serotype A, strain B3263/91, Chicken
Date of authorisation: 24/01/2003, Revision: 7, Withdrawn, Last updated: 03/10/2022 -
List item
Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 10/10/2009,
, Revision: 11, Authorised, Last updated: 08/06/2022
-
List item
Veterinary medicine European public assessment report (EPAR): Eravac
Inactivated rabbit haemorrhagic disease type 2 virus (RHDV2), strainV-1037, Rabbits
Date of authorisation: 22/09/2016, Revision: 6, Authorised, Last updated: 02/09/2021 -
List item
Human medicine European public assessment report (EPAR): Byfavo
remimazolam besilate, Conscious Sedation
Date of authorisation: 26/03/2021,, Revision: 5, Authorised, Last updated: 18/04/2023
-
List item
Human medicine European public assessment report (EPAR): Aldara
imiquimod, Condylomata Acuminata; Keratosis; Keratosis, Actinic; Carcinoma, Basal Cell
Date of authorisation: 18/09/1998, Revision: 30, Authorised, Last updated: 20/03/2023 -
List item
Veterinary medicine European public assessment report (EPAR): Suvaxyn Aujeszky 783 + O/W
live attenuated Aujeszky's disease virus, Pigs
Date of authorisation: 07/08/1998, Revision: 15, Authorised, Last updated: 22/02/2021 -
List item
Human medicine European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly) (updated)
tadalafil, Hypertension, Pulmonary
Date of authorisation: 01/10/2008, Revision: 16, Authorised, Last updated: 12/05/2023